News Releases May 2, 2024 Ventyx Biosciences to Report First Quarter 2024 Financial Results on May 9, 2024 Read more March 11, 2024 Ventyx Biosciences Reports Clinical Data for its NLRP3 Inhibitor Portfolio and Provides Pipeline Updates at Virtual Investor Event Read more March 7, 2024 Ventyx Biosciences Announces $100 Million Private Placement of Common Stock Read more March 6, 2024 Ventyx Biosciences to Participate in Two Upcoming Investor Conferences Read more March 4, 2024 Ventyx Biosciences to Host Virtual Investor Event on March 11, 2024 Read more February 27, 2024 Ventyx Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Corporate Progress Read more February 22, 2024 Ventyx Biosciences to Present Results of the Phase 2 Trial of VTX002 in Ulcerative Colitis at the 19th Congress of the European Crohn's and Colitis Organisation (ECCO) Read more February 6, 2024 Ventyx Biosciences to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference Read more November 21, 2023 Ventyx Biosciences to Participate in the 35th Annual Piper Sandler Healthcare Conference Read more November 10, 2023 Ventyx Biosciences to Participate in the Jefferies London Healthcare Conference Read more Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Next page › Last page » Displaying 1 - 10 of 53